Silexion Therapeutics completes development plan for next-generation siRNA candidate SIL204; plans to present at 2025 NeauxCancer Conference: Grand Cayman, Cayman Islands Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback